Comment on ‘Sequential nephron blockade vs . sequential renin–angiotensin system blockade on central and ambulatory blood pressure in resistant hypertension: A randomized clinical trial’

Key Result

Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension is discussed in this commentary, which presents no new clinical data.

Key Points

• This research aims to compare the effects of sequential nephron blockade and sequential renin–angiotensin system blockade on blood pressure in individuals with resistant hypertension.
• Randomized clinical trial design
• Participants with resistant hypertension were assigned to receive either nephron blockade or renin-angiotensin system blockade
• Ambulatory and central blood pressure measurements were taken
• No datasets were generated or analyzed during this research, indicating a lack of findings to report.